Major improvement in thyroid cancer survival of elderly patients in the Nordic countries
Authors' conclusion
Age disadvantage in TC survival was for the most part corrected over the 50-year period, and the remaining task is to boost survival for the oldest patients.
Study context
- Population
- Patients with thyroid cancer (TC) in Denmark, Finland, Norway and Sweden, 1972–2021
- Outcome
- Relative 5-year survival by age
- Follow-up
- 5 years
Methodological detailsNORDCAN database, Denmark, Finland, Norway and Sweden, 50-year period
- NORDCAN database
- Denmark, Finland, Norway and Sweden
- 50-year period
Main finding
As reported in the abstract
Relative 5-year survival in TC
1972-1976: 5-year survival in Finland, Norway and Sweden
90% or higher
2017-2021: survival for all women and Danish men up to age 69 years
about 90% or higher
2017-2021: older women
80%
Observational data: associations, not effects.
Original publication
Major improvement in thyroid cancer survival of elderly patients in the Nordic countries. Eur J Endocrinol. Published 4 March 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →